Skip to main content

Table 5 Pre-and post-operative echo

From: The safety of introducing a new generation TAVR device: one departments experience from introducing a second generation repositionable TAVR

Pre-operative

Lotus (n = 53)

Sapien (n = 47)

p-value

 Ejection Fraction

  EF > 50%

67.9% (36)

55.3% (26)

0.2203

  EF 30-50%

26.4% (14)

29.8% (14)

0.8241

  EF < 30%

5.7% (3)

14.9% (7)

0.1831

 Mitral regurgitation

  None

5.7% (3)

4.3% (2)

1.0000

  Trace

34% (18)

23.4% (11)

0.3797

  Mild

43.4% (23)

48.9% (23)

0.6882

  Mild-Moderate

7.5% (4)

17% (8)

0.2179

  Moderate

7.5% (4)

6.4% (3)

1.0000

 Aortic stenosis

  Peak velocity

4.5 (0.5)

4.2 (0.6)

0.0141

  Peak gradient

80 (17.9)

71.7 (18.8)

0.0275

  Aortic valve area (cm2)

0.6 (0.2)

0.6 (0.2)

0.0860

Post-operative

Lotus (n = 50)

Sapien (n = 42)

p-value

 Ejection fraction

  EF > 50%

74% (37)

64.3% (27)

0.2171

  EF 30-50%

24% (12)

26.2% (11)

1.0000

  EF < 30%

2% (1)

9.5% (4)

0.1841

 Aortic regurgitation

  None

58% (29)

26.2% (11)

0.0020

  Trace

32% (16)

21.4% (9)

0.2505

  Mild

10% (5)

47.6% (20)

0.0002

  Mild-moderate

0% (0)

4.8% (2)

0.2184

  Moderate

0% (0)

0% (0)

 

 Mitral regurgitation

  None

4% (2)

0% (0)

0.4982

  Trace

36% (18)

47.6% (20)

0.4114

  Mild

46% (23)

42.9% (18)

0.4881

  Mild-Moderate

0% (0)

4.8% (2)

0.1669

  Moderate

14% (7)

4.8% (2)

0.1669

 Aortic stenosis

  Peak velocity

2.1 (0.4)

2 (0.5)

0.0838

  Peak gradient

18.9 (6.9)

16.5 (8.3)

0.1405

  1. Pre-and post-operative echocardiography re-assessed by one blinded investigator